0 reactions
The global demand for intracranial stents was valued at USD 2358.90 million in 2023 and is expected to reach USD 3951.60 million in 2032, growing at a CAGR of 5.90% between 2024 and 2032.The global intracranial stents market is witnessing significant growth, driven by the increasing prevalence of neurological disorders, advancements in medical technology, and the growing demand for minimally invasive procedures. Intracranial stents are medical devices used to treat brain aneurysms and stenosis of intracranial arteries. These stents help in maintaining the patency of blood vessels in the brain, thereby preventing strokes and other serious neurological conditions. The market for intracranial stents is expected to expand rapidly over the next decade, propelled by various factors.
Browse the full report at https://www.credenceresearch.com/report/intracranial-stents-market
Rising Prevalence of Neurological Disorders
One of the primary factors contributing to the growth of the intracranial stents market is the rising prevalence of neurological disorders. Conditions such as brain aneurysms, strokes, and intracranial atherosclerosis are becoming increasingly common due to factors like aging populations, unhealthy lifestyles, and genetic predispositions. According to the World Health Organization (WHO), strokes are the second leading cause of death globally, emphasizing the urgent need for effective treatment options. Intracranial stents offer a promising solution, significantly reducing the risk of recurrent strokes and improving patient outcomes.
Technological Advancements
Technological advancements in the design and manufacturing of intracranial stents are also driving market growth. Modern stents are now more flexible, durable, and biocompatible, enhancing their performance and reducing the risk of complications. The development of drug-eluting stents, which release medication to prevent restenosis, has further improved the efficacy of these devices. Additionally, the integration of advanced imaging technologies, such as high-resolution angiography and magnetic resonance imaging (MRI), has enabled more precise placement of stents, increasing the success rates of these interventions.
Minimally Invasive Procedures
The growing preference for minimally invasive procedures is another key factor boosting the intracranial stents market. Traditional surgical methods for treating brain aneurysms and arterial stenosis involve significant risks and long recovery times. In contrast, intracranial stenting procedures are less invasive, requiring only a small incision to insert the stent through the blood vessels. This approach not only reduces the risk of complications but also shortens hospital stays and accelerates patient recovery. As a result, both patients and healthcare providers are increasingly opting for stenting procedures over conventional surgeries.
Expanding Applications
The applications of intracranial stents are expanding beyond the treatment of aneurysms and stenosis. Researchers are exploring the use of these stents in treating other neurological conditions, such as arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs). The versatility of intracranial stents in addressing various cerebrovascular abnormalities is expected to open new avenues for market growth. Furthermore, ongoing clinical trials and studies are likely to provide more evidence supporting the safety and efficacy of these devices, encouraging their wider adoption.
Regional Market Insights
The intracranial stents market is geographically diverse, with significant growth opportunities in various regions. North America currently dominates the market, primarily due to the high prevalence of neurological disorders, advanced healthcare infrastructure, and strong presence of key market players. Europe follows closely, driven by increasing awareness about neurological health and favorable reimbursement policies.
However, the Asia-Pacific region is expected to witness the highest growth rate in the coming years. Factors such as the rising geriatric population, improving healthcare facilities, and increasing healthcare expenditure are contributing to the market expansion in countries like China, India, and Japan. Additionally, government initiatives to enhance healthcare infrastructure and promote medical tourism are further boosting the demand for advanced neurological treatments, including intracranial stenting procedures.
Challenges and Future Outlook
Despite the promising growth prospects, the intracranial stents market faces certain challenges. High costs of stenting procedures, limited availability of skilled neurosurgeons, and potential risks associated with stent implantation are some of the factors that could hinder market growth. However, ongoing research and development efforts aimed at improving the safety and affordability of these devices are likely to address these challenges.
Key Players
Acandis GmbH
Abbott Laboratories
Medtronic plc
Stryker Corporation
MicroPort Scientific Corporation
DePuy Synthes Companies
Boston Scientific Corporation
Penumbra, Inc.
Balt Extrusion
Segmentation
By Type of Stents
Self-Expanding Stents
Balloon-Expandable Stents
By Material Composition
Metallic Stents
Polymer-Based Stents
By Application
Ischemic Stroke
Intracranial Aneurysms
Intracranial Stenosis
By End User
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
By Region
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
About Us:
Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.
Contact:
Credence Research
Please contact us at + 91 6232 49 3207
Email: [email protected]
Browse the full report at https://www.credenceresearch.com/report/intracranial-stents-market
Rising Prevalence of Neurological Disorders
One of the primary factors contributing to the growth of the intracranial stents market is the rising prevalence of neurological disorders. Conditions such as brain aneurysms, strokes, and intracranial atherosclerosis are becoming increasingly common due to factors like aging populations, unhealthy lifestyles, and genetic predispositions. According to the World Health Organization (WHO), strokes are the second leading cause of death globally, emphasizing the urgent need for effective treatment options. Intracranial stents offer a promising solution, significantly reducing the risk of recurrent strokes and improving patient outcomes.
Technological Advancements
Technological advancements in the design and manufacturing of intracranial stents are also driving market growth. Modern stents are now more flexible, durable, and biocompatible, enhancing their performance and reducing the risk of complications. The development of drug-eluting stents, which release medication to prevent restenosis, has further improved the efficacy of these devices. Additionally, the integration of advanced imaging technologies, such as high-resolution angiography and magnetic resonance imaging (MRI), has enabled more precise placement of stents, increasing the success rates of these interventions.
Minimally Invasive Procedures
The growing preference for minimally invasive procedures is another key factor boosting the intracranial stents market. Traditional surgical methods for treating brain aneurysms and arterial stenosis involve significant risks and long recovery times. In contrast, intracranial stenting procedures are less invasive, requiring only a small incision to insert the stent through the blood vessels. This approach not only reduces the risk of complications but also shortens hospital stays and accelerates patient recovery. As a result, both patients and healthcare providers are increasingly opting for stenting procedures over conventional surgeries.
Expanding Applications
The applications of intracranial stents are expanding beyond the treatment of aneurysms and stenosis. Researchers are exploring the use of these stents in treating other neurological conditions, such as arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs). The versatility of intracranial stents in addressing various cerebrovascular abnormalities is expected to open new avenues for market growth. Furthermore, ongoing clinical trials and studies are likely to provide more evidence supporting the safety and efficacy of these devices, encouraging their wider adoption.
Regional Market Insights
The intracranial stents market is geographically diverse, with significant growth opportunities in various regions. North America currently dominates the market, primarily due to the high prevalence of neurological disorders, advanced healthcare infrastructure, and strong presence of key market players. Europe follows closely, driven by increasing awareness about neurological health and favorable reimbursement policies.
However, the Asia-Pacific region is expected to witness the highest growth rate in the coming years. Factors such as the rising geriatric population, improving healthcare facilities, and increasing healthcare expenditure are contributing to the market expansion in countries like China, India, and Japan. Additionally, government initiatives to enhance healthcare infrastructure and promote medical tourism are further boosting the demand for advanced neurological treatments, including intracranial stenting procedures.
Challenges and Future Outlook
Despite the promising growth prospects, the intracranial stents market faces certain challenges. High costs of stenting procedures, limited availability of skilled neurosurgeons, and potential risks associated with stent implantation are some of the factors that could hinder market growth. However, ongoing research and development efforts aimed at improving the safety and affordability of these devices are likely to address these challenges.
Key Players
Acandis GmbH
Abbott Laboratories
Medtronic plc
Stryker Corporation
MicroPort Scientific Corporation
DePuy Synthes Companies
Boston Scientific Corporation
Penumbra, Inc.
Balt Extrusion
Segmentation
By Type of Stents
Self-Expanding Stents
Balloon-Expandable Stents
By Material Composition
Metallic Stents
Polymer-Based Stents
By Application
Ischemic Stroke
Intracranial Aneurysms
Intracranial Stenosis
By End User
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
By Region
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
About Us:
Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.
Contact:
Credence Research
Please contact us at + 91 6232 49 3207
Email: [email protected]
| 35,000 mlx | |
| 38 | |
| 0 |